Loading clinical trials...
Loading clinical trials...
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Correction of Infraorbital Hollowing
Conditions
Interventions
JUVÉDERM VOLBELLA® XC injectable gel
Locations
15
United States
Christopher I. Zoumalan MD Inc.
Beverly Hills, California, United States
Steve Yoelin MD Medical Associate, Inc.
Newport Beach, California, United States
Cosmetic Laser Dermatology
San Diego, California, United States
Facesplus, Inc.
San Diego, California, United States
Art of Skin MD
Solana Beach, California, United States
Steven Fagien M.D.F.A.C.S.
Boca Raton, Florida, United States
Start Date
January 26, 2018
Primary Completion Date
October 17, 2018
Completion Date
August 22, 2019
Last Updated
November 15, 2021
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions